Ezinsukwini ezimbalwa ezedlule, i-Hebei Depond inamalungelo obunikazi amabili ngaphezulu agunyazwe i-State Intellectual Property Office, elinye lamagama welungelo lobunikazi "i-compound enrofloxacin oral liquid kanye nendlela yayo yokulungiselela", inombolo yelungelo lobunikazi ithi ZL 2019 1 0327540. enye ithi "Ammonium pharmaceutical composition", inombolo ye-patent 1019 kanye nesicelo se-ZL 2019 0839594.8.
Ngaso sonke isikhathi, ochwepheshe be-Depond bebezibophezele ocwaningweni nasekuthuthukisweni kobuchwepheshe bezidakamizwa zezilwane, nangocwaningo lokuhlola oluqhubekayo, ukuze kuthuthukiswe ukusebenza kahle komkhiqizo.
Eminyakeni yamuva nje, i-Hebei Depond Company igxile ekwandiseni ukutshalwa kwezimali ocwaningweni lwesayensi, yenza ngenkuthalo ukuqamba okusha kwezobuchwepheshe, kanye nekhwalithi yomkhiqizo ethuthukisiwe yathuthukiswa. Ithimba lezobuchwepheshe linqobe ubunzima obuningi enqubweni yocwaningo nentuthuko, lanqoba inkinga eyodwa ngemva kwenye, alizange lithuthukise umphumela wokwelapha wemikhiqizo yenkampani kuphela, kodwa futhi lathola amalungelo obunikazi bokusungulwa eChina. Ukuthuthukiswa okuqhubekayo kocwaningo lwesayensi kuye kwathuthukisa ukuncintisana okuyinhloko kwenkampani futhi kwanikeza ukusekelwa okuqinile kwesayensi nobuchwepheshe ekuthuthukisweni kwenkampani.
Isikhathi sokuthumela: Jun-15-2022